Navigation Links
Acorda Therapeutics to Host Analyst and Investor Reception

ual results to differ materially, including Acorda Therapeutics' ability to successfully market and sell Zanaflex Capsules, the risk of unfavorable results from future studies of Fampridine-SR, delays in obtaining or failure to obtain FDA approval of Fampridine-SR, competition, the ability to obtain additional financing to support Acorda Therapeutics' operations, unfavorable results from its preclinical programs, and failure to protect its intellectual property or to defend against the intellectual property claims of others. These and other risks are described in greater detail in Acorda Therapeutics' filings with the Securities and Exchange Commission. Acorda Therapeutics may not actually achieve the goals or plans described in its forward-looking statements, and investors should not place undue reliance on these statements. Acorda Therapeutics disclaims any intent or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

About Acorda Therapeutics

Acorda Therapeutics is a biotechnology company developing therapies for SCI, MS and related nervous system disorders. The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. For full prescribing information, please go to www.zanaflexcapsules.com. Acorda's lead clinical stage product, Fampridine-SR, recently completed a Phase 3 study in people with MS. The Company's pipeline includes a number of products in development for the treatment, regeneration and repair of the spinal cord and brain.

Contact

Acorda Therapeutics
Erica Wishner, 914-347-4300 ext. 162
ewishner@acorda.com


'"/>




Page: 1 2

Related medicine technology :

1. Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting
2. Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting
3. Acorda Therapeutics Presentation of Fampridine-SR Phase 3 Data Selected for Scientific Highlights Program at the American Academy of Neurology Meeting
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
7. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
8. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
9. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
10. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
11. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Acorda Therapeutics Host Analyst and Investor Reception
(Date:4/21/2015)... CORAL SPRINGS, Florida , April 21, 2015 /PRNewswire/ ... in the U.S. are expected to grow at a ... for companies & vendors that provide technology services for ... Companies in focus today are: Surna Inc. (OTC: SRNA), ... (OTC: MJNA), Breathe, E-Cigs Corp. (OTC: BVAP), 22 nd ...
(Date:4/21/2015)... , April 21, 2015  Decision Diagnostics ... administrator and the exclusive worldwide sales, service and ... the FDA-cleared Green Alternative Strip, specifically designed to ... LifeScan OneTouch Ultra family of glucose testing meters, ... announced today that Johnson & Johnson/Lifescan has requested ...
(Date:4/21/2015)... , April 21, 2015  Navitas has launched ... a wide range of offerings for life sciences clients. ... an integrated platform enabling seamless flow of data across ... the Aviator launch, Navitas worked closely with Oracle to ... and Oracle,s CTMS in the Cloud. ...
Breaking Medicine Technology:New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 2New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 3New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 4New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 5New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 6New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 7Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case 2Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case 3Navitas Launches Aviator - Cloud Based Platforms for Oracle Solutions 2Navitas Launches Aviator - Cloud Based Platforms for Oracle Solutions 3Navitas Launches Aviator - Cloud Based Platforms for Oracle Solutions 4
... Md., Dec. 15, 2011  GP Strategies Corporation (NYSE: ... merger of GP Strategies Corporation with and ... current holding company structure. General Physics, which is the ... surviving legal corporation and will be renamed GP Strategies ...
... the industry leader in innovative shape memory orthopedic devices, today ... United States Copyright and Patent Office for its innovative shape ... was granted December 6, 2011 for a "Method and Apparatus ... memory polymers are advanced materials that can "remember" more than ...
Cached Medicine Technology:GP Strategies Shareholders Approve Elimination of Holding Company Structure and Renaming of General Physics Corporation 2GP Strategies Shareholders Approve Elimination of Holding Company Structure and Renaming of General Physics Corporation 3MedShape, Inc. Awarded U.S. Patent for Deploying Shape Memory Polymer Devices in Medical Applications 2
(Date:4/21/2015)... Los Angeles, CA (PRWEB) April 21, 2015 ... Instead, it opened its doors today in the leafy, ... with a refreshed look and a new theme of “Disconnect ... the new owner of the award-winning day spa, announces ... in time for special Mother’s Day offerings that help celebrate ...
(Date:4/21/2015)... Utah (PRWEB) April 21, 2015 Zane ... businesses, announced today its CEO Rick Lindquist has been ... for 2015. , According to Rick Lindquist, “There is ... industry, and Zane Benefits’ small business solutions are at ... recognition provided by Employee Benefit Adviser’s Rising Stars.” , ...
(Date:4/21/2015)... has released a new blog post explaining the importance of ... on a uto insurance prices . , Drivers ... for advantageous auto insurance discounts. Clients can now review multiple ... will also help them get the best rates in their ... cost coverage is no longer difficult as there are multiple ...
(Date:4/21/2015)... Optimity Advisors ( Optimity), ... that helps clients in complex industries navigate rapid ... Association of Community Affiliated Plans (ACAP) ... 58 local, not-for-profit, community-affiliated Safety Net Health Plans ... primarily enrolled in public or state-sponsored coverage programs, ...
(Date:4/21/2015)... Quark Software Inc. has introduced ... solution that enables large enterprises to streamline the ... With Quark Procedure Management, corporate writers and subject ... to save, search and update, which is critical ... issues. Examples of policies and procedures include employee ...
Breaking Medicine News(10 mins):Health News:Larchmont Sanctuary Spa Revealed as New Name For Neighborhood Spa; New Owner, New Eco Offerings & New Theme: “Disconnect to Reconnect” 2Health News:Larchmont Sanctuary Spa Revealed as New Name For Neighborhood Spa; New Owner, New Eco Offerings & New Theme: “Disconnect to Reconnect” 3Health News:Zane Benefits’ CEO Named Top 20 Rising Stars 2Health News:Auto Insurance Quotes Offer Excellent Security for A Car 2Health News:Optimity Advisors Named Preferred Vendor by the Association of Community Affiliated Plans (ACAP) 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 3
... By Jenifer Goodwin HealthDay Reporter , THURSDAY, ... falling behind on your mortgage payments hurts more than just ... with the struggle can also harm your physical and psychological ... on nearly 2,500 Americans who took part in the Health ...
... News) -- Most Americans consume too much sodium, and new ... of dietary salt, according to a new study by federal ... with increased risk of high blood pressure, which can lead ... people aged 2 years and older should limit daily sodium ...
... University of Houston (UH) are recommending a new strategy for ... diseases. In an invited review published in the ... at the Center for Nuclear Receptors and Cell Signaling (CNRCS) ... the team,s 1996 discovery of the estrogen receptor beta (ERβ). ...
... 20 (HealthDay News) -- There,s a suicide every 15 minutes in ... her own life there are many more who think about, plan ... The analysis of 2008-09 data from the National Survey on Drug ... range from about 1 in 50 adults in Georgia (2.1 percent) ...
... HOUSTON -- (Oct. 20, 2011) -- Bioengineers from Rice University ... a new "law of biology" can predict when a critically ... treatment is likely to prevent it. "We want to ... the principal investigator on a new $1.5 million grant from ...
... announce findings published in the October 20 issue of ... the inhibition of both microRNA-33a and microRNA-33b (miR-33a/b) with ... cause a sustained increase in high density lipoprotein cholesterol ... in the last decade has opened new insights for ...
Cached Medicine News:Health News:Foreclosure Crisis Threatening Americans' Health: Study 2Health News:Foreclosure Crisis Threatening Americans' Health: Study 3Health News:U.S. Diet Still Has Too Much Salt, CDC Warns 2Health News:New drug strategies for Alzheimer's, multiple sclerosis examined at UH 2Health News:Suicide Rates Vary by Region: CDC 2Health News:Cloudy with a chance of sudden death 2Health News:Cloudy with a chance of sudden death 3Health News:Novel therapeutic target identified to decrease triglycerides and increase 'good' cholesterol 2
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: